https://stock.noler.com/us/stock/musclepharm-corporation https://stock.noler.com/us/stock/musclepharm-corporation/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/musclepharm-corporation/accounts-payable https://stock.noler.com/us/stock/musclepharm-corporation/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/musclepharm-corporation/accounts-payable-and-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/accounts-payable-current-and-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/accounts-receivable https://stock.noler.com/us/stock/musclepharm-corporation/accounts-receivable-gross-current https://stock.noler.com/us/stock/musclepharm-corporation/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/musclepharm-corporation/accrual-at-carrying-value https://stock.noler.com/us/stock/musclepharm-corporation/accrual-payments https://stock.noler.com/us/stock/musclepharm-corporation/accrued-bonuses-current-and-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/accrued-employee-benefits-current https://stock.noler.com/us/stock/musclepharm-corporation/accrued-income-taxes-current https://stock.noler.com/us/stock/musclepharm-corporation/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/musclepharm-corporation/accrued-liabilities-current https://stock.noler.com/us/stock/musclepharm-corporation/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/accrued-payroll-taxes-current-and-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/accrued-professional-fees-current https://stock.noler.com/us/stock/musclepharm-corporation/accumulated-amortization-of-noncurrent-deferred-finance-costs https://stock.noler.com/us/stock/musclepharm-corporation/accumulated-depreciation https://stock.noler.com/us/stock/musclepharm-corporation/acquired-assets https://stock.noler.com/us/stock/musclepharm-corporation/acquired-current-assets https://stock.noler.com/us/stock/musclepharm-corporation/acquired-current-assets-other https://stock.noler.com/us/stock/musclepharm-corporation/acquired-current-assets-receivables https://stock.noler.com/us/stock/musclepharm-corporation/acquired-current-liabilities-accounts-payable https://stock.noler.com/us/stock/musclepharm-corporation/acquired-current-liabilities-other https://stock.noler.com/us/stock/musclepharm-corporation/acquired-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/musclepharm-corporation/acquired-inventory https://stock.noler.com/us/stock/musclepharm-corporation/acquired-liabilities https://stock.noler.com/us/stock/musclepharm-corporation/acquired-net https://stock.noler.com/us/stock/musclepharm-corporation/acquired-property-plant-and-equipment https://stock.noler.com/us/stock/musclepharm-corporation/acquisition-bargain-purchase-gain-recognized-amount https://stock.noler.com/us/stock/musclepharm-corporation/acquisition-consideration-transferred https://stock.noler.com/us/stock/musclepharm-corporation/acquisition-contingent-consideration-asset https://stock.noler.com/us/stock/musclepharm-corporation/additional-paid-in-capital https://stock.noler.com/us/stock/musclepharm-corporation/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/musclepharm-corporation/adjustment-for-amortization https://stock.noler.com/us/stock/musclepharm-corporation/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/musclepharm-corporation/advertising-expense https://stock.noler.com/us/stock/musclepharm-corporation/aggregate-indebtedness https://stock.noler.com/us/stock/musclepharm-corporation/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/musclepharm-corporation/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/musclepharm-corporation/allowance-for-doubtful-accounts-receivable-recoveries https://stock.noler.com/us/stock/musclepharm-corporation/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/musclepharm-corporation/amortization https://stock.noler.com/us/stock/musclepharm-corporation/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/musclepharm-corporation/amortization-of-deferred-charges https://stock.noler.com/us/stock/musclepharm-corporation/amortization-of-financing-costs https://stock.noler.com/us/stock/musclepharm-corporation/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/musclepharm-corporation/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/musclepharm-corporation/aoci https://stock.noler.com/us/stock/musclepharm-corporation/asset-impairment-charges https://stock.noler.com/us/stock/musclepharm-corporation/assets-fair-value-disclosure https://stock.noler.com/us/stock/musclepharm-corporation/assets-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/assets-of-disposal-group-including-discontinued-operation https://stock.noler.com/us/stock/musclepharm-corporation/available-for-sale-current https://stock.noler.com/us/stock/musclepharm-corporation/available-for-sale-debt-current https://stock.noler.com/us/stock/musclepharm-corporation/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/musclepharm-corporation/bank-overdrafts https://stock.noler.com/us/stock/musclepharm-corporation/basic-shares https://stock.noler.com/us/stock/musclepharm-corporation/business-acquisition-equity-interest-issued-or-issuable-value-assigned https://stock.noler.com/us/stock/musclepharm-corporation/business-acquisition-equity-interests-issued-or-issuable-number-of-shares-issued https://stock.noler.com/us/stock/musclepharm-corporation/business-acquisition-share-price https://stock.noler.com/us/stock/musclepharm-corporation/business-acquisitions-pro-forma-income-loss-from-before-changes-in-accounting-and-extraordinary-items-net-of-tax https://stock.noler.com/us/stock/musclepharm-corporation/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/musclepharm-corporation/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/musclepharm-corporation/buybacks-share-repurchases https://stock.noler.com/us/stock/musclepharm-corporation/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/musclepharm-corporation/buybacks-stock-repurchased-shares https://stock.noler.com/us/stock/musclepharm-corporation/buybacks-treasury-shares-acquired https://stock.noler.com/us/stock/musclepharm-corporation/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/musclepharm-corporation/capital-expenditures https://stock.noler.com/us/stock/musclepharm-corporation/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/musclepharm-corporation/capital-lease-obligations https://stock.noler.com/us/stock/musclepharm-corporation/capital-lease-obligations-current https://stock.noler.com/us/stock/musclepharm-corporation/capital-lease-obligations-incurred https://stock.noler.com/us/stock/musclepharm-corporation/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/capital-leases-balance-sheet-assets-by-major-class-net https://stock.noler.com/us/stock/musclepharm-corporation/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/musclepharm-corporation/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/musclepharm-corporation/capital-leases-future-minimum-payments-due-in-five-years https://stock.noler.com/us/stock/musclepharm-corporation/capital-leases-future-minimum-payments-due-in-four-years https://stock.noler.com/us/stock/musclepharm-corporation/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/musclepharm-corporation/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/musclepharm-corporation/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/musclepharm-corporation/capital-leases-future-minimum-payments-net-minimum-payments https://stock.noler.com/us/stock/musclepharm-corporation/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/musclepharm-corporation/capital-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/musclepharm-corporation/capital-leases-lessee-balance-sheet-assets-by-major-class-accumulated-deprecation https://stock.noler.com/us/stock/musclepharm-corporation/cash https://stock.noler.com/us/stock/musclepharm-corporation/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/musclepharm-corporation/cash-and-equivalents https://stock.noler.com/us/stock/musclepharm-corporation/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/musclepharm-corporation/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/musclepharm-corporation/cash-change https://stock.noler.com/us/stock/musclepharm-corporation/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/musclepharm-corporation/cash-fdic-insured-amount https://stock.noler.com/us/stock/musclepharm-corporation/cash-flow-breakdown https://stock.noler.com/us/stock/musclepharm-corporation/cash-uninsured-amount https://stock.noler.com/us/stock/musclepharm-corporation/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/musclepharm-corporation/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/musclepharm-corporation/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/musclepharm-corporation/common-stock-no-par-value https://stock.noler.com/us/stock/musclepharm-corporation/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/musclepharm-corporation/common-stock-value https://stock.noler.com/us/stock/musclepharm-corporation/comprehensive-income https://stock.noler.com/us/stock/musclepharm-corporation/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/musclepharm-corporation/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/musclepharm-corporation/contractual-obligation https://stock.noler.com/us/stock/musclepharm-corporation/contractual-obligation-due-after-fifth-year https://stock.noler.com/us/stock/musclepharm-corporation/contractual-obligation-due-in-fifth-year https://stock.noler.com/us/stock/musclepharm-corporation/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/musclepharm-corporation/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/musclepharm-corporation/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/musclepharm-corporation/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/musclepharm-corporation/contractual-obligation-future-minimum-payments-due-remainder-of-fiscal-year https://stock.noler.com/us/stock/musclepharm-corporation/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/musclepharm-corporation/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/musclepharm-corporation/convertible-debt https://stock.noler.com/us/stock/musclepharm-corporation/convertible-debt-current https://stock.noler.com/us/stock/musclepharm-corporation/convertible-long-term-notes-payable https://stock.noler.com/us/stock/musclepharm-corporation/convertible-notes-payable https://stock.noler.com/us/stock/musclepharm-corporation/convertible-notes-payable-current https://stock.noler.com/us/stock/musclepharm-corporation/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/musclepharm-corporation/cost-of-revenue https://stock.noler.com/us/stock/musclepharm-corporation/cost-of-revenue-2 https://stock.noler.com/us/stock/musclepharm-corporation/cover-page-shares-outstanding https://stock.noler.com/us/stock/musclepharm-corporation/credit-card-receivables https://stock.noler.com/us/stock/musclepharm-corporation/current-assets https://stock.noler.com/us/stock/musclepharm-corporation/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/musclepharm-corporation/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/musclepharm-corporation/current-income-tax-expense-benefit https://stock.noler.com/us/stock/musclepharm-corporation/current-liabilities https://stock.noler.com/us/stock/musclepharm-corporation/current-portion-of-long-term-debt https://stock.noler.com/us/stock/musclepharm-corporation/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/musclepharm-corporation/customer-advances-current https://stock.noler.com/us/stock/musclepharm-corporation/customer-deposits-current https://stock.noler.com/us/stock/musclepharm-corporation/customer-deposits-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/damages-paid-value https://stock.noler.com/us/stock/musclepharm-corporation/damages-sought-value https://stock.noler.com/us/stock/musclepharm-corporation/debt-basis-spread-on-variable-rate https://stock.noler.com/us/stock/musclepharm-corporation/debt-carrying-amount https://stock.noler.com/us/stock/musclepharm-corporation/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/musclepharm-corporation/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/musclepharm-corporation/debt-conversion-converted-instrument-warrants-or-options-issued https://stock.noler.com/us/stock/musclepharm-corporation/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/musclepharm-corporation/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/musclepharm-corporation/debt-convertible-conversion-price https://stock.noler.com/us/stock/musclepharm-corporation/debt-default-shortterm-debt-amount https://stock.noler.com/us/stock/musclepharm-corporation/debt-face-amount https://stock.noler.com/us/stock/musclepharm-corporation/debt-increase-decrease-other-net https://stock.noler.com/us/stock/musclepharm-corporation/debt-interest-rate https://stock.noler.com/us/stock/musclepharm-corporation/debt-issuance-costs https://stock.noler.com/us/stock/musclepharm-corporation/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/musclepharm-corporation/debt-longterm-and-shortterm-combined-amount https://stock.noler.com/us/stock/musclepharm-corporation/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/musclepharm-corporation/debt-maturing-in-year-four https://stock.noler.com/us/stock/musclepharm-corporation/debt-maturing-in-year-three https://stock.noler.com/us/stock/musclepharm-corporation/debt-maturing-in-year-two https://stock.noler.com/us/stock/musclepharm-corporation/debt-periodic-payment https://stock.noler.com/us/stock/musclepharm-corporation/debt-unamortized-discount https://stock.noler.com/us/stock/musclepharm-corporation/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/musclepharm-corporation/deferred-finance-costs-current-gross https://stock.noler.com/us/stock/musclepharm-corporation/deferred-finance-costs-current-net https://stock.noler.com/us/stock/musclepharm-corporation/deferred-finance-costs-net https://stock.noler.com/us/stock/musclepharm-corporation/deferred-finance-costs-noncurrent-gross https://stock.noler.com/us/stock/musclepharm-corporation/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/musclepharm-corporation/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/musclepharm-corporation/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/musclepharm-corporation/deferred-income-tax-liabilities https://stock.noler.com/us/stock/musclepharm-corporation/deferred-revenue https://stock.noler.com/us/stock/musclepharm-corporation/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-gross https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-inventory https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-net https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-other https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-tax-credit-carryforwards-general-business https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-allowance-for-doubtful-accounts https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/musclepharm-corporation/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/musclepharm-corporation/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/musclepharm-corporation/defined-contribution-plan-maximum-annual-contributions-per-employee-amount https://stock.noler.com/us/stock/musclepharm-corporation/deposits-assets-current https://stock.noler.com/us/stock/musclepharm-corporation/depreciation https://stock.noler.com/us/stock/musclepharm-corporation/depreciation-and-amortization https://stock.noler.com/us/stock/musclepharm-corporation/depreciation-and-amortization-expense https://stock.noler.com/us/stock/musclepharm-corporation/derivative-assets-current https://stock.noler.com/us/stock/musclepharm-corporation/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/musclepharm-corporation/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/musclepharm-corporation/derivative-gain-on-derivative https://stock.noler.com/us/stock/musclepharm-corporation/derivative-liabilities https://stock.noler.com/us/stock/musclepharm-corporation/derivative-liabilities-current https://stock.noler.com/us/stock/musclepharm-corporation/diluted-shares https://stock.noler.com/us/stock/musclepharm-corporation/dilutive-shares https://stock.noler.com/us/stock/musclepharm-corporation/disposal-group-including-discontinued-operation-inventory https://stock.noler.com/us/stock/musclepharm-corporation/dividends-declared https://stock.noler.com/us/stock/musclepharm-corporation/dividends-preferred-stock https://stock.noler.com/us/stock/musclepharm-corporation/due-to-related-parties-current https://stock.noler.com/us/stock/musclepharm-corporation/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/musclepharm-corporation/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/musclepharm-corporation/embedded-derivative-fair-value-of-embedded-derivative-liability https://stock.noler.com/us/stock/musclepharm-corporation/entity-wide-revenue-major-customer-percentage https://stock.noler.com/us/stock/musclepharm-corporation/eps https://stock.noler.com/us/stock/musclepharm-corporation/eps-basic https://stock.noler.com/us/stock/musclepharm-corporation/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/musclepharm-corporation/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/musclepharm-corporation/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/musclepharm-corporation/fair-value-assumptions-weighted-average-expected-dividend https://stock.noler.com/us/stock/musclepharm-corporation/fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/musclepharm-corporation/fair-value-of-assets-acquired https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-liability https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-liability-current https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-liability-payments-due https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-liability-payments-due-year-five https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-principal-payments https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/musclepharm-corporation/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/musclepharm-corporation/financing-cash-flow https://stock.noler.com/us/stock/musclepharm-corporation/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/musclepharm-corporation/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/musclepharm-corporation/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/musclepharm-corporation/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/musclepharm-corporation/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/musclepharm-corporation/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/musclepharm-corporation/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/musclepharm-corporation/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/musclepharm-corporation/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/musclepharm-corporation/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/musclepharm-corporation/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/musclepharm-corporation/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/musclepharm-corporation/foreign-currency-transaction-loss-before-tax https://stock.noler.com/us/stock/musclepharm-corporation/foreign-earnings https://stock.noler.com/us/stock/musclepharm-corporation/foreign-pretax-income https://stock.noler.com/us/stock/musclepharm-corporation/form-d-corporate-securities https://stock.noler.com/us/stock/musclepharm-corporation/form-d-other https://stock.noler.com/us/stock/musclepharm-corporation/form-d-stocks https://stock.noler.com/us/stock/musclepharm-corporation/former-gain-contingency-recognized-in-current-period https://stock.noler.com/us/stock/musclepharm-corporation/furniture-and-fixtures-gross https://stock.noler.com/us/stock/musclepharm-corporation/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/musclepharm-corporation/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/musclepharm-corporation/gain-loss-on-sale-of-accounts-receivable https://stock.noler.com/us/stock/musclepharm-corporation/gain-loss-on-sale-of-business https://stock.noler.com/us/stock/musclepharm-corporation/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/musclepharm-corporation/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/musclepharm-corporation/gain-or-loss-on-sale-of-stock-in-subsidiary https://stock.noler.com/us/stock/musclepharm-corporation/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/musclepharm-corporation/general-and-administrative-expense https://stock.noler.com/us/stock/musclepharm-corporation/gross-profit https://stock.noler.com/us/stock/musclepharm-corporation/impaired-assets-to-be-disposed-of-by-method-other-than-sale-amount-of-impairment-loss https://stock.noler.com/us/stock/musclepharm-corporation/impairment-lessor-asset-under-operating-lease https://stock.noler.com/us/stock/musclepharm-corporation/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/musclepharm-corporation/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/musclepharm-corporation/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/musclepharm-corporation/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/musclepharm-corporation/income-tax https://stock.noler.com/us/stock/musclepharm-corporation/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/musclepharm-corporation/income-tax-examination-estimate-of-possible-loss https://stock.noler.com/us/stock/musclepharm-corporation/income-tax-examination-penalties-accrued https://stock.noler.com/us/stock/musclepharm-corporation/income-tax-examination-penalties-and-interest-expense https://stock.noler.com/us/stock/musclepharm-corporation/income-tax-examination-penalties-expense https://stock.noler.com/us/stock/musclepharm-corporation/income-taxes-paid https://stock.noler.com/us/stock/musclepharm-corporation/income-taxes-paid-2 https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-book-overdrafts https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-customer-deposits https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-deposits-outstanding https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-fair-value-of-unhedged-derivative-instruments https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-inventories https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-other-accrued-liabilities https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-prepaid-expenses-other https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-restricted-cash-for-operating-activities https://stock.noler.com/us/stock/musclepharm-corporation/increase-decrease-in-restructuring-reserve https://stock.noler.com/us/stock/musclepharm-corporation/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/musclepharm-corporation/indefinite-lived-license-agreements https://stock.noler.com/us/stock/musclepharm-corporation/insider-transactions-corporate-securities https://stock.noler.com/us/stock/musclepharm-corporation/insider-transactions-other https://stock.noler.com/us/stock/musclepharm-corporation/insider-transactions-preferred https://stock.noler.com/us/stock/musclepharm-corporation/insider-transactions-preferred/purchases https://stock.noler.com/us/stock/musclepharm-corporation/insider-transactions-stock-options https://stock.noler.com/us/stock/musclepharm-corporation/insider-transactions-stock-units https://stock.noler.com/us/stock/musclepharm-corporation/insider-transactions-warrants https://stock.noler.com/us/stock/musclepharm-corporation/intangible-assets-gross-excluding-goodwill https://stock.noler.com/us/stock/musclepharm-corporation/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/musclepharm-corporation/interest-and-debt-expense https://stock.noler.com/us/stock/musclepharm-corporation/interest-expense https://stock.noler.com/us/stock/musclepharm-corporation/interest-expense-borrowings https://stock.noler.com/us/stock/musclepharm-corporation/interest-expense-on-debt https://stock.noler.com/us/stock/musclepharm-corporation/interest-expense-other https://stock.noler.com/us/stock/musclepharm-corporation/interest-expense-related-party https://stock.noler.com/us/stock/musclepharm-corporation/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/musclepharm-corporation/interest-income-other https://stock.noler.com/us/stock/musclepharm-corporation/interest-paid https://stock.noler.com/us/stock/musclepharm-corporation/interest-paid-net https://stock.noler.com/us/stock/musclepharm-corporation/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/inventory https://stock.noler.com/us/stock/musclepharm-corporation/inventory-finished-goods https://stock.noler.com/us/stock/musclepharm-corporation/inventory-gross https://stock.noler.com/us/stock/musclepharm-corporation/inventory-raw-materials https://stock.noler.com/us/stock/musclepharm-corporation/inventory-valuation-reserves https://stock.noler.com/us/stock/musclepharm-corporation/inventory-work-in-process https://stock.noler.com/us/stock/musclepharm-corporation/inventory-write-down https://stock.noler.com/us/stock/musclepharm-corporation/investing-cash-flow https://stock.noler.com/us/stock/musclepharm-corporation/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/musclepharm-corporation/labor-and-related-expense https://stock.noler.com/us/stock/musclepharm-corporation/lease-cost https://stock.noler.com/us/stock/musclepharm-corporation/lease-incentive-payable-current https://stock.noler.com/us/stock/musclepharm-corporation/leasehold-improvements-gross https://stock.noler.com/us/stock/musclepharm-corporation/legal-fees https://stock.noler.com/us/stock/musclepharm-corporation/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/musclepharm-corporation/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/musclepharm-corporation/liabilities-assumed https://stock.noler.com/us/stock/musclepharm-corporation/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/musclepharm-corporation/liabilities-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/liabilities-other-than-longterm-debt-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/liability-for-claims-and-claims-adjustment-expense https://stock.noler.com/us/stock/musclepharm-corporation/license-costs https://stock.noler.com/us/stock/musclepharm-corporation/line-of-credit https://stock.noler.com/us/stock/musclepharm-corporation/line-of-credit-facility-current-borrowing-capacity https://stock.noler.com/us/stock/musclepharm-corporation/line-of-credit-facility-interest-rate https://stock.noler.com/us/stock/musclepharm-corporation/line-of-credit-facility-interest-rate-at-period-end https://stock.noler.com/us/stock/musclepharm-corporation/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/musclepharm-corporation/lines-of-credit-current https://stock.noler.com/us/stock/musclepharm-corporation/litigation-settlement-amount https://stock.noler.com/us/stock/musclepharm-corporation/litigation-settlement-expense https://stock.noler.com/us/stock/musclepharm-corporation/litigation-settlement-interest https://stock.noler.com/us/stock/musclepharm-corporation/loans-payable https://stock.noler.com/us/stock/musclepharm-corporation/long-term-debt https://stock.noler.com/us/stock/musclepharm-corporation/long-term-investments https://stock.noler.com/us/stock/musclepharm-corporation/marketable-securities-gain-loss https://stock.noler.com/us/stock/musclepharm-corporation/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/musclepharm-corporation/marketing-and-advertising-expense https://stock.noler.com/us/stock/musclepharm-corporation/net-cash-from-financing-activities https://stock.noler.com/us/stock/musclepharm-corporation/net-cash-from-investing-activities https://stock.noler.com/us/stock/musclepharm-corporation/net-cash-from-operating-activities https://stock.noler.com/us/stock/musclepharm-corporation/net-change-in-cash https://stock.noler.com/us/stock/musclepharm-corporation/net-income https://stock.noler.com/us/stock/musclepharm-corporation/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/musclepharm-corporation/non-hedging-derivatives-gain-loss-net https://stock.noler.com/us/stock/musclepharm-corporation/noncash-contribution-expense https://stock.noler.com/us/stock/musclepharm-corporation/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/musclepharm-corporation/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/musclepharm-corporation/noncash-or-part-noncash-acquisition-noncash-financial-or-equity-instrument-consideration-shares-issued https://stock.noler.com/us/stock/musclepharm-corporation/noncash-or-part-noncash-acquisition-other-liabilities-assumed https://stock.noler.com/us/stock/musclepharm-corporation/noncash-or-part-noncash-acquisition-value-of-assets-acquired https://stock.noler.com/us/stock/musclepharm-corporation/notes-and-loans-payable-current https://stock.noler.com/us/stock/musclepharm-corporation/notes-payable https://stock.noler.com/us/stock/musclepharm-corporation/notes-payable-current https://stock.noler.com/us/stock/musclepharm-corporation/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/musclepharm-corporation/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/musclepharm-corporation/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/musclepharm-corporation/oci-net-of-tax https://stock.noler.com/us/stock/musclepharm-corporation/officers-compensation https://stock.noler.com/us/stock/musclepharm-corporation/operating-cash-flow https://stock.noler.com/us/stock/musclepharm-corporation/operating-expenses https://stock.noler.com/us/stock/musclepharm-corporation/operating-income https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-assets https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-cost https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-impairment-loss https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-liability https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-liability-current https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-payments https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-payments-due https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-payments-due-2 https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-payments-due-current https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/musclepharm-corporation/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/musclepharm-corporation/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/musclepharm-corporation/operating-leases-rent-expense-net https://stock.noler.com/us/stock/musclepharm-corporation/operating-loss-carryforwards https://stock.noler.com/us/stock/musclepharm-corporation/other-accrued-liabilities-current https://stock.noler.com/us/stock/musclepharm-corporation/other-asset-impairment-charges https://stock.noler.com/us/stock/musclepharm-corporation/other-assets-miscellaneous-current https://stock.noler.com/us/stock/musclepharm-corporation/other-assets-miscellaneous-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/other-commitment https://stock.noler.com/us/stock/musclepharm-corporation/other-current-assets https://stock.noler.com/us/stock/musclepharm-corporation/other-expenses https://stock.noler.com/us/stock/musclepharm-corporation/other-general-and-administrative-expense https://stock.noler.com/us/stock/musclepharm-corporation/other-income https://stock.noler.com/us/stock/musclepharm-corporation/other-inventory-purchased-goods https://stock.noler.com/us/stock/musclepharm-corporation/other-long-term-debt https://stock.noler.com/us/stock/musclepharm-corporation/other-long-term-debt-current https://stock.noler.com/us/stock/musclepharm-corporation/other-long-term-debt-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/other-noncash-expense https://stock.noler.com/us/stock/musclepharm-corporation/other-noncash-income-expense https://stock.noler.com/us/stock/musclepharm-corporation/other-noncurrent-assets https://stock.noler.com/us/stock/musclepharm-corporation/other-noncurrent-liabilities https://stock.noler.com/us/stock/musclepharm-corporation/other-nonoperating-expense https://stock.noler.com/us/stock/musclepharm-corporation/other-nonoperating-gains-losses https://stock.noler.com/us/stock/musclepharm-corporation/other-nonoperating-income https://stock.noler.com/us/stock/musclepharm-corporation/other-nonoperating-income-expense https://stock.noler.com/us/stock/musclepharm-corporation/other-operating-activities-cash-flow-statement https://stock.noler.com/us/stock/musclepharm-corporation/other-prepaid-expense-current https://stock.noler.com/us/stock/musclepharm-corporation/other-restructuring-costs https://stock.noler.com/us/stock/musclepharm-corporation/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/musclepharm-corporation/paid-in-capital-other https://stock.noler.com/us/stock/musclepharm-corporation/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/musclepharm-corporation/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/musclepharm-corporation/paid-in-capital-shares-issued-ownshare-lending-arrangement-issuance-costs https://stock.noler.com/us/stock/musclepharm-corporation/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/musclepharm-corporation/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/musclepharm-corporation/payments-for-proceeds-from-businesses-and-interest-in-affiliates https://stock.noler.com/us/stock/musclepharm-corporation/payments-for-purchase-of-other-assets https://stock.noler.com/us/stock/musclepharm-corporation/payments-for-purchase-of-other-assets-1 https://stock.noler.com/us/stock/musclepharm-corporation/payments-for-restructuring https://stock.noler.com/us/stock/musclepharm-corporation/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/musclepharm-corporation/payments-of-financing-costs https://stock.noler.com/us/stock/musclepharm-corporation/payments-of-merger-related-costs-financing-activities https://stock.noler.com/us/stock/musclepharm-corporation/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/musclepharm-corporation/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/musclepharm-corporation/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/musclepharm-corporation/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/musclepharm-corporation/payments-to-acquire-trading-securities-heldforinvestment https://stock.noler.com/us/stock/musclepharm-corporation/preferred-shares-facts https://stock.noler.com/us/stock/musclepharm-corporation/preferred-stock-dividends-income-statement-impact https://stock.noler.com/us/stock/musclepharm-corporation/preferred-stock-liquidation-preference-value https://stock.noler.com/us/stock/musclepharm-corporation/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/musclepharm-corporation/preferred-stock-shares-authorized https://stock.noler.com/us/stock/musclepharm-corporation/preferred-stock-shares-issued https://stock.noler.com/us/stock/musclepharm-corporation/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/musclepharm-corporation/prepaid-advertising https://stock.noler.com/us/stock/musclepharm-corporation/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/musclepharm-corporation/prepaid-expense-and-other-assets-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/prepaid-expense-current https://stock.noler.com/us/stock/musclepharm-corporation/prepaid-expense-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/prepaid-insurance https://stock.noler.com/us/stock/musclepharm-corporation/prepaid-rent https://stock.noler.com/us/stock/musclepharm-corporation/prepaid-royalties https://stock.noler.com/us/stock/musclepharm-corporation/prepaid-taxes https://stock.noler.com/us/stock/musclepharm-corporation/pretax-income https://stock.noler.com/us/stock/musclepharm-corporation/pretax-income-domestic https://stock.noler.com/us/stock/musclepharm-corporation/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-contributed-capital https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-convertible-debt https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-divestiture-of-businesses https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-divestiture-of-interest-in-subsidiaries-and-affiliates https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-issuance-of-secured-debt https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-license-fees-received https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-loans https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-notes-payable https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-other-debt https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-related-party-debt https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-repayments-of-accounts-receivable-securitization https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-repayments-of-bank-overdrafts https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-repayments-of-secured-debt https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-sale-and-collection-of-notes-receivable https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-sale-of-available-for-sale-equity https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-sale-of-trading-securities-heldforinvestment https://stock.noler.com/us/stock/musclepharm-corporation/proceeds-from-stock-issued https://stock.noler.com/us/stock/musclepharm-corporation/professional-fees https://stock.noler.com/us/stock/musclepharm-corporation/profit-loss https://stock.noler.com/us/stock/musclepharm-corporation/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/musclepharm-corporation/property-plant-and-equipment-gross https://stock.noler.com/us/stock/musclepharm-corporation/property-plant-equipment https://stock.noler.com/us/stock/musclepharm-corporation/provision-for-doubtful-accounts https://stock.noler.com/us/stock/musclepharm-corporation/public-float https://stock.noler.com/us/stock/musclepharm-corporation/real-estate-owned-valuation-allowance-amounts-applied https://stock.noler.com/us/stock/musclepharm-corporation/realized-gains-on-securities https://stock.noler.com/us/stock/musclepharm-corporation/related-party-transaction-amounts-of-transaction https://stock.noler.com/us/stock/musclepharm-corporation/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/musclepharm-corporation/repayments-of-debt https://stock.noler.com/us/stock/musclepharm-corporation/repayments-of-lines-of-credit https://stock.noler.com/us/stock/musclepharm-corporation/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/musclepharm-corporation/repayments-of-notes-payable https://stock.noler.com/us/stock/musclepharm-corporation/repayments-of-other-debt https://stock.noler.com/us/stock/musclepharm-corporation/repayments-of-related-party-debt https://stock.noler.com/us/stock/musclepharm-corporation/repayments-of-secured-debt https://stock.noler.com/us/stock/musclepharm-corporation/repayments-of-unsecured-debt https://stock.noler.com/us/stock/musclepharm-corporation/research-and-development https://stock.noler.com/us/stock/musclepharm-corporation/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/musclepharm-corporation/restricted-stock-award-forfeitures https://stock.noler.com/us/stock/musclepharm-corporation/restructuring-charges https://stock.noler.com/us/stock/musclepharm-corporation/restructuring-costs https://stock.noler.com/us/stock/musclepharm-corporation/restructuring-reserve https://stock.noler.com/us/stock/musclepharm-corporation/restructuring-reserve-current https://stock.noler.com/us/stock/musclepharm-corporation/restructuring-reserve-noncurrent https://stock.noler.com/us/stock/musclepharm-corporation/restructuring-settlement-and-impairment-provisions https://stock.noler.com/us/stock/musclepharm-corporation/retained-earnings https://stock.noler.com/us/stock/musclepharm-corporation/revenue https://stock.noler.com/us/stock/musclepharm-corporation/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/musclepharm-corporation/revenue-remaining-performance-obligation-percentage https://stock.noler.com/us/stock/musclepharm-corporation/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/musclepharm-corporation/sales-discounts-goods https://stock.noler.com/us/stock/musclepharm-corporation/sales-discounts-returns-and-allowances-goods https://stock.noler.com/us/stock/musclepharm-corporation/sales-revenue-goods-gross https://stock.noler.com/us/stock/musclepharm-corporation/sales-revenue-net https://stock.noler.com/us/stock/musclepharm-corporation/secured-debt https://stock.noler.com/us/stock/musclepharm-corporation/secured-debt-current https://stock.noler.com/us/stock/musclepharm-corporation/security-deposit https://stock.noler.com/us/stock/musclepharm-corporation/selling-and-marketing-expense https://stock.noler.com/us/stock/musclepharm-corporation/senior-notes-current https://stock.noler.com/us/stock/musclepharm-corporation/settlement-agreement-consideration https://stock.noler.com/us/stock/musclepharm-corporation/severance-costs https://stock.noler.com/us/stock/musclepharm-corporation/sga-expense https://stock.noler.com/us/stock/musclepharm-corporation/shareholders-equity https://stock.noler.com/us/stock/musclepharm-corporation/shares-authorized https://stock.noler.com/us/stock/musclepharm-corporation/shares-issued https://stock.noler.com/us/stock/musclepharm-corporation/shares-issued-price-per-share https://stock.noler.com/us/stock/musclepharm-corporation/shares-repurchased https://stock.noler.com/us/stock/musclepharm-corporation/short-term-borrowings https://stock.noler.com/us/stock/musclepharm-corporation/short-term-debt https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-rsu-change https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/musclepharm-corporation/stock-award-rsu-vested-in-period-total-fair-value https://stock.noler.com/us/stock/musclepharm-corporation/stock-based-compensation https://stock.noler.com/us/stock/musclepharm-corporation/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/musclepharm-corporation/stock-compensation-unrecognized-cost-share-based-awards-other-than-options https://stock.noler.com/us/stock/musclepharm-corporation/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/musclepharm-corporation/stock-granted-value-share-based-compensation https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-new-shares-sold https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-for-acquisitions https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-for-stock-awards https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-shares-change https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-shares-purchase-of-assets https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-shares-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-shares-stock-splits https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-value-conversion-of-units https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-value-restricted-stock-award-forfeitures https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-shares-issued-value-share-based-compensation-forfeited https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/musclepharm-corporation/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/musclepharm-corporation/stock-option-exercise-price-increase https://stock.noler.com/us/stock/musclepharm-corporation/stock-option-plan-expense https://stock.noler.com/us/stock/musclepharm-corporation/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/musclepharm-corporation/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/musclepharm-corporation/stock-options-exercisable-number https://stock.noler.com/us/stock/musclepharm-corporation/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/musclepharm-corporation/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/musclepharm-corporation/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/musclepharm-corporation/stock-options-grants-in-period https://stock.noler.com/us/stock/musclepharm-corporation/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/musclepharm-corporation/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/musclepharm-corporation/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/musclepharm-corporation/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/musclepharm-corporation/stock-options-outstanding-number https://stock.noler.com/us/stock/musclepharm-corporation/stock-split-ratio https://stock.noler.com/us/stock/musclepharm-corporation/stockholders-equity-other https://stock.noler.com/us/stock/musclepharm-corporation/sublease-income https://stock.noler.com/us/stock/musclepharm-corporation/supplies https://stock.noler.com/us/stock/musclepharm-corporation/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/musclepharm-corporation/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/musclepharm-corporation/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/musclepharm-corporation/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/musclepharm-corporation/tax-reconciliation-disposition-of-assets https://stock.noler.com/us/stock/musclepharm-corporation/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/musclepharm-corporation/tax-reconciliation-nondeductible-expense-amortization https://stock.noler.com/us/stock/musclepharm-corporation/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/musclepharm-corporation/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/musclepharm-corporation/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/musclepharm-corporation/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/musclepharm-corporation/temporary-equity-redemption-price-per-share https://stock.noler.com/us/stock/musclepharm-corporation/total-assets https://stock.noler.com/us/stock/musclepharm-corporation/total-liabilities https://stock.noler.com/us/stock/musclepharm-corporation/total-liabilities-and-equity https://stock.noler.com/us/stock/musclepharm-corporation/total-long-term-debt https://stock.noler.com/us/stock/musclepharm-corporation/trading-securities-current https://stock.noler.com/us/stock/musclepharm-corporation/trading-securities-realized-gain-loss https://stock.noler.com/us/stock/musclepharm-corporation/trading-securities-unrealized-holding-gain-loss https://stock.noler.com/us/stock/musclepharm-corporation/treasury-stock-acquired-average-cost-per-share https://stock.noler.com/us/stock/musclepharm-corporation/treasury-stock-common-shares https://stock.noler.com/us/stock/musclepharm-corporation/treasury-stock-common-value https://stock.noler.com/us/stock/musclepharm-corporation/treasury-stock-shares https://stock.noler.com/us/stock/musclepharm-corporation/treasury-stock-value https://stock.noler.com/us/stock/musclepharm-corporation/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/musclepharm-corporation/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/musclepharm-corporation/unrealized-gain-loss-on-investments https://stock.noler.com/us/stock/musclepharm-corporation/unrealized-gain-loss-on-securities https://stock.noler.com/us/stock/musclepharm-corporation/unrecognized-tax-benefits https://stock.noler.com/us/stock/musclepharm-corporation/unsecured-debt https://stock.noler.com/us/stock/musclepharm-corporation/unsecured-debt-current https://stock.noler.com/us/stock/musclepharm-corporation/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/musclepharm-corporation/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/musclepharm-corporation/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/musclepharm-corporation/utb-interest-on-income-taxes-expense https://stock.noler.com/us/stock/musclepharm-corporation/valuation-allowance-amount https://stock.noler.com/us/stock/musclepharm-corporation/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/musclepharm-corporation/valuation-allowances-and-reserves-adjustments https://stock.noler.com/us/stock/musclepharm-corporation/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/musclepharm-corporation/valuation-allowances-and-reserves-recoveries https://stock.noler.com/us/stock/musclepharm-corporation/variable-lease-cost https://stock.noler.com/us/stock/musclepharm-corporation/warrant-exercise-price-increase https://stock.noler.com/us/stock/musclepharm-corporation/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/musclepharm-corporation/weighted-average-number-of-shares-issued-basic